Fimvo SGA on 24 March 2026 - Board continues the work to fight against falsified medicines

Fimvo’s SGA was held on 24 March 2026. Our Board of Directors, consisting of representatives from across the pharmaceutical supply chain, will continue in the same familiar composition and remains firmly committed to its work to prevent falsified medicines. 

Board of Directors: 
Ritva Lehtonen, Chair (Pharma Industry Finland) 
Heikki Bothas (Finnish Generic Pharmaceutical Association) 
Sampsa Kavander (Orion Corporation) 
Petter Sandström (Pharmaceutical Wholesalers) 
Inka Puumalainen (Association of Finnish Pharmacies)
Sanna Raappana (Suppliers of Parallel Imported Medicines in Finland)

Read more about our Board of Directors here